Weko Medical's Transcatheter Aortic Valve Replacement System Listed Among Hubei Province's '61020' Sci-Tech Innovation Achievements

On January 4, the Hubei Provincial Science and Technology Innovation Conference was grandly held at Hongshan Hall, with a significant release.2025 Hubei Province "61020" Scientific and Technological Innovation AchievementsList.

Hubei Province's "61020" Scientific and Technological Innovation Achievements System is the core measure for building the province's high-level scientific and technological innovation hub. Focusing on national strategic needs and Hubei's advantageous fields, it emphasizes breakthroughs in six major fundamental research areas, overcomes 10 key core technologies, and develops 20 landmark innovative products each year. The achievements highlight originality, leadership, and significance, collectively demonstrating Hubei's systematic efforts in critical areas such as artificial intelligence, advanced manufacturing, biomedicine, modern agriculture, new materials, and new energy.

Vickor's independently developed"Transcatheter Aortic Valve Replacement System"With breakthrough technological innovations and significant industrial value,Successfully selected into the list of 20 landmark innovative products, with outstanding strength leading industrial transformation and injecting strong momentum into high-quality development.

DOCS VALVE^®The transcatheter aortic valve replacement system, with fully independent intellectual property rights, innovatively covers dual indications of stenosis and regurgitation, successfully breaking through the technical bottlenecks of large annulus and pure regurgitation anchoring.The integrated valve frame structure combines the core technologies of "3D dual-bend adjustment for the aorta" and "bidirectional fixation with forward deployment," significantly improving the coaxial positioning accuracy of the valve. This ensures safe and stable deployment, enabling localized anesthesia during surgery and eliminating the need for pacemaker use.

Advanced original design updates the concept of transcatheter aortic valve replacement therapy, offering doctors and patients a more reliable treatment option.